Zim Laboratories block deals, bulk deals, insider trading and stake changes
NSE: ZIMLABBSE: 541400Pharmaceuticals & BiotechnologySmall Cap
Last close ₹126.22down ₹5.90 (4.47%)BSE ₹126.60
Share price at the NSE close on 23 Oct 2026. Previous close ₹132.12.
52-week range of traded prices to 23 Oct 2026
₹59.31Low, 30 Mar 2026₹159.81High, 12 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹677 Cr1,933rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 6 Aug 2026
- 183.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 19 May 2026
- 2.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 6 Aug 2026
- 1.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- 1.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 19 May 2026
- 0.42
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,16,71445.7% delivered
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Zim Laboratories promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade
- Others: no market trade
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Zim Laboratories insider trading
All 18 disclosures on record.Insider trading, all companies
Jul 2026
- Chandrashekhar Dhundiraj Mainde₹1.14 Cr97,451 sharesBought · Designated Person · 22 Jul 2026 · disclosed 29 Sep
Jun 2026
- Anwar Daud₹0.10 Cr8,000 sharesBought · Promoter · 29 Jun 2026 · disclosed 3 Jul
- Anwar Daud₹0.03 Cr2,000 sharesBought · Promoter · 25 Jun 2026 · disclosed 30 Jun
- Anwar Daud₹0.90 Cr80,000 sharesBought · Promoter · 11 Jun 2026 · disclosed 15 Jun
- Zulfiquar Murtaza Kamal₹0.90 Cr80,000 sharesSold or invoked · Promoter And Designated Person · 11 Jun 2026 · disclosed 15 Jun
Apr 2026
- Chandrashekhar Dhundiraj Mainde₹0.41 Cr48,726 sharesBought · Designated Person · 24 Apr 2026 · disclosed 12 May
Jun 2023
- Mr. Niraj Pukhraj Dhadiwal₹0.54 Cr50,000 sharesSold or invoked · Designated Person · 22 Jun 2023 · disclosed 27 Jun
- Mr. Vijay Fudke₹0.10 Cr9,054 sharesSold or invoked · Designated Person · 12 Jun 2023 · disclosed 16 Jun
- Mr. Vijay Fudke₹0.06 Cr5,473 sharesSold or invoked · Designated Person · 9 Jun 2023 · disclosed 16 Jun
May 2023
- Mr. Vijay Fudke₹0.11 Cr10,473 sharesSold or invoked · Designated Person · 29 May 2023 · disclosed 16 Jun
- Mr. Vijay Fudke₹0.15 Cr15,000 sharesSold or invoked · Designated Person · 26 May 2023 · disclosed 1 Jun
Dec 2022
- Mr. Prakash Pralahadrao Sapkal₹2.65 Cr2,51,200 sharesBought · Designated Person · 29 Dec 2022 · disclosed 3 Jan 2023
- Mrs. Tasneem Daud₹0.21 Cr20,000 sharesBought · Promoter · 29 Dec 2022 · disclosed 3 Jan 2023
- Mr. Hasan Z. Kamal₹0.73 Cr69,600 sharesBought · Promoter · 29 Dec 2022 · disclosed 3 Jan 2023
- ZULFIQUAR MURTAZA KAMAL₹8.40 Cr7,96,040 sharesBought · Promoter And Designated Person · 29 Dec 2022 · disclosed 3 Jan 2023
- Mr. Dipendra Mahule₹0.25 Cr24,084 sharesBought · Designated Person · 29 Dec 2022 · disclosed 3 Jan 2023
- Mrs. Sabbah Kamal₹11 Cr10,00,000 sharesBought · Promoter · 29 Dec 2022 · disclosed 3 Jan 2023
- Dr. Anwar Siraj Daud₹94 Cr88,90,880 sharesBought · Promoter And Designated Person · 29 Dec 2022 · disclosed 3 Jan 2023
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Zim Laboratories stake sales and purchases
All 7 disclosures on record.
Mar 2026
- AcquiredMr. Mathew Cyriac7.50% of the company40,12,702 sharesholds 19.34% after13 Mar 2026 · filed under the 2% rule · Open Market
Feb 2025
- SoldMathew Cyriac along with PAC1.83% of the company8,89,434 sharesholds 13.00% after10 Feb 2025 · filed under the 2% rule · Open Market
Sep 2024
- AcquiredMr. Mathew Cyriac alongwith PAC0.25% of the company1,23,698 sharesholds 14.83% after3 Sep 2024 · filed under the 2% rule · Open Market
Mar 2024
- SoldMr. Mathew Cyriac2.40% of the company11,70,860 sharesholds 14.58% after27 Mar 2024 · filed under the 2% rule · Open Market
Nov 2023
- SoldMr. Mathew Cyriac2.17% of the company10,56,867 sharesholds 16.97% after7 Nov 2023 · filed under the 2% rule · Open Market
Aug 2023
- SoldMathew Cyriac2.72% of the company13,23,173 sharesholds 19.14% after4 Aug 2023 · filed under the 2% rule · Open Market
Earlier, Jun 2023 to Jun 2023Hide earlier
Jun 2023
- SoldMr. Zakir Vali7.18% of the company35,00,000 sharesholds 10.36% after12 Jun 2023 · filed under the 2% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Zim Laboratories block deals and bulk deals
Last 12 months, since 23 Oct 2025: 6 bulk deals, ₹41 Cr bought and ₹40 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Tuesday 11 Nov 20252 firms · ₹28 Cr bought · ₹28 Cr soldNet bought ₹76,800
- BoughtELIMATH ADVISORS PRIVATE LIMITEDBought 38,40,000 at ₹73.477.88% of the company₹28 Cr
- SoldELIZABETH MATHEWSold 38,40,000 at ₹73.457.88% of the company₹28 Cr
Wednesday 29 Oct 20251 firm · ₹2.17 Cr bought · ₹1.17 Cr soldNet bought ₹0.99 Cr
- Both waysAJIT RAMKARAN SARDABought 2,65,483 at ₹81.58Sold 1,42,892 at ₹82.020.54% of the companyNet +1,22,591 shares₹2.17 Cr bought
Friday 24 Oct 20252 firms · ₹10 Cr bought · ₹11 Cr soldNet sold ₹0.50 Cr
- SoldMATHEW CYRIACSold 15,69,000 at ₹68.843.22% of the company₹11 Cr
- BoughtELIMATH ADVISORS PRIVATE LIMITEDBought 14,97,124 at ₹68.793.07% of the company₹10 Cr
Thursday 17 Jul 20252 firms · ₹21 Cr bought · ₹21 Cr soldNet nil
- SoldELIZABETH MATHEWSold 17,94,000 at ₹115.313.68% of the company₹21 Cr
- BoughtMATHEW CYRIACBought 17,94,000 at ₹115.313.68% of the company₹21 Cr
Thursday 20 Mar 20251 firm · ₹0.42 Cr bought · ₹4.46 Cr soldNet sold ₹4.05 Cr
- Both waysYUGA STOCKS AND COMMODITIES PRIVATE LIMITEDBought 41,859 at ₹99.73Sold 4,77,321 at ₹93.510.98% of the companyNet −4,35,462 shares₹0.42 Cr bought
Wednesday 19 Mar 20252 firms · ₹5.43 Cr bought · ₹5.43 Cr soldNet nil
- SoldELIMATH ADVISORS PRIVATE LIMITEDSold 6,44,000 at ₹84.241.32% of the company₹5.43 Cr
- BoughtELIZABETH MATHEWBought 6,44,000 at ₹84.241.32% of the company₹5.43 Cr
Tuesday 18 Mar 20252 firms · ₹6.44 Cr bought · ₹6.44 Cr soldNet nil
- BoughtELIZABETH MATHEWBought 7,96,500 at ₹80.871.63% of the company₹6.44 Cr
- SoldMATHEW CYRIACSold 7,96,500 at ₹80.871.63% of the company₹6.44 Cr
Thursday 13 Mar 20254 firms · ₹65 Cr bought · ₹65 Cr soldNet nil
- BoughtELIZABETH MATHEWBlock dealBought 39,95,324 at ₹81.718.20% of the company₹33 Cr
- BoughtELIZABETH MATHEWBought 39,95,324 at ₹81.718.20% of the company₹33 Cr
- SoldMATHEW CYRIACBlock dealSold 39,95,324 at ₹81.718.20% of the company₹33 Cr
- SoldMATHEW CYRIACSold 39,95,324 at ₹81.718.20% of the company₹33 Cr
Tuesday 4 Feb 20252 firms · ₹8.99 Cr bought · ₹8.99 Cr soldNet nil
- SoldELIMATH ADVISORS PRIVATE LIMITEDSold 9,00,000 at ₹99.851.85% of the company₹8.99 Cr
- BoughtELIZABETH MATHEWBought 9,00,000 at ₹99.851.85% of the company₹8.99 Cr
Tuesday 3 Sep 20242 firms · ₹20 Cr bought · ₹20 Cr soldNet nil
- BoughtELIMATH ADVISORS PRIVATE LIMITEDBought 16,60,000 at ₹119.353.41% of the company₹20 Cr
- SoldMATHEW CYRIACSold 16,60,000 at ₹119.353.41% of the company₹20 Cr
Wednesday 24 Apr 20243 firms · ₹11 Cr bought · ₹8.79 Cr soldNet bought ₹1.76 Cr
- Both waysASHAPURA COMMODITIESBought 3,01,621 at ₹123.50Sold 1,36,828 at ₹125.800.62% of the companyNet +1,64,793 shares₹3.73 Cr bought
- Both waysHRTI PRIVATE LIMITEDBought 2,29,160 at ₹121.76Sold 2,49,531 at ₹121.920.51% of the companyNet −20,371 shares₹2.79 Cr bought
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 3,35,460 at ₹120.44Sold 3,35,460 at ₹120.160.69% of the companyNet nil₹4.04 Cr bought
Wednesday 27 Mar 20242 firms · ₹3.38 Cr bought · ₹3.38 Cr soldNet nil
- SoldMATHEW CYRIACSold 3,51,860 at ₹96.100.72% of the company₹3.38 Cr
- BoughtYUGA STOCKS AND COMMODITIES PRIVATE LIMITED .Bought 3,51,860 at ₹96.100.72% of the company₹3.38 Cr
Friday 4 Aug 20231 firm · ₹4.32 Cr bought · ₹4.31 Cr soldNet bought ₹84,059
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 3,00,211 at ₹143.98Sold 3,00,211 at ₹143.700.62% of the companyNet nil₹4.32 Cr bought
Friday 28 Jul 20231 firm · ₹4.03 Cr bought · ₹4.03 Cr soldNet nil
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 3,04,887 at ₹132.03Sold 3,04,887 at ₹132.060.63% of the companyNet nil₹4.03 Cr bought
Monday 12 Jun 202311 firms · ₹34 Cr bought · ₹71 Cr soldNet sold ₹37 Cr
- SoldZAKIRBHAI SALEHBHAI VALISold 31,00,000 at ₹102.636.36% of the company₹32 Cr
- Both waysMANSI SHARE & STOCK ADVISORS PRIVATE LIMITEDBought 5,01,064 at ₹102.66Sold 26,057 at ₹103.271.03% of the companyNet +4,75,007 shares₹5.14 Cr bought
- Both waysMANSI SHARES & STOCK ADVISORS PVT LTDBought 30,347 at ₹106.88Sold 4,55,338 at ₹108.040.93% of the companyNet −4,24,991 shares₹0.32 Cr bought
- SoldNAZARETH SHERWIN SAVIO JOSEPHSold 3,62,500 at ₹115.840.74% of the company₹4.20 Cr
- SoldVALI ZAKIR HUSAINSold 4,00,000 at ₹103.640.82% of the company₹4.15 Cr
- Both waysSETU SECURITIES PVT. LTD.Bought 5,31,862 at ₹102.93Sold 1,77,708 at ₹104.811.09% of the companyNet +3,54,154 shares₹5.47 Cr bought
- Both waysSETU SECURITIES PVT LTDBought 1,70,253 at ₹108.12Sold 5,10,040 at ₹106.611.05% of the companyNet −3,39,787 shares₹1.84 Cr bought
- BoughtNASSER ZAKI ABBASBought 3,10,000 at ₹105.340.64% of the company₹3.27 Cr
- Both waysF3 ADVISORS PRIVATE LIMITEDBought 3,76,537 at ₹103.42Sold 3,76,537 at ₹106.870.77% of the companyNet nil₹3.89 Cr bought
- Both waysBONANZA COMMODITY BROKERS PRIVATE LIMITEDBought 8,22,253 at ₹103.65Sold 8,07,251 at ₹106.761.69% of the companyNet +15,002 shares₹8.52 Cr bought
- Both waysGRAVITON RESEARCH CAPITAL LLPBought 4,91,786 at ₹110.40Sold 4,91,786 at ₹110.261.01% of the companyNet nil₹5.43 Cr bought
Thursday 8 Jun 20231 firm · ₹0 bought · ₹2.77 Cr soldNet sold ₹2.77 Cr
- SoldPAREKH DEVANGSold 2,62,334 at ₹105.680.54% of the company₹2.77 Cr
BonusEach share became 3 on 22 Dec 2022. The lines below are on the share count before it.
Wednesday 23 Mar 20222 firms · ₹59 Cr bought · ₹59 Cr soldNet nil
- SoldELIZABETH MATHEWSold 35,50,900 at ₹165.0021.86% of the company₹59 Cr
- BoughtMATHEW CYRIACBought 35,50,900 at ₹165.0021.86% of the company₹59 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. The latest 50 deals, on record since listing on 8 Jun 2018.